Expert Group Consensus From The Arabian Peninsula On The Diagnosis Of Late Onset Pompe Disease for orthopedists
![](/.imaging/webp/sanofi-templates/article-hero-w768/dam/campus-sanofi-sa/new/science/hero/jcr_content-(36).jpg/jcr:content/jcr_content%20(36).jpg)
Objective and Method
![](/dam/jcr:e93698c9-9a0c-4e10-86ad-ad9971224b06/Asset%204@4x-100%20(5).jpg)
Consensus based on literature supporting clinical presentation and recommendations
Literature Analysis on LOPD Symptoms (Orthopedics): Hierarchy of Evidence
![](/dam/jcr:1637c7b8-8b58-435b-89db-9c26f3642642/Asset%206@4x%20(1).jpg)
Orthopedics-Specific
Clinical Presentation for Pediatric/Juvenile* LOPD Proposed During the First Meeting
![](/dam/jcr:5c66aa72-f11d-4d97-bd6b-9922b56bbbe5/bh.jpg)
Orthopedics-Specific
Clinical Presentation for Pediatric/Juvenile* LOPD Proposed During the First Meeting
![](/dam/jcr:e04d2d0f-54dc-4f1a-9c91-c97206b01bf9/Asset%209@4x.jpg)
Conclusion
![](/dam/jcr:ae770ff3-c926-45b1-8e34-7c39110d0fa8/Asset%207@2x%20(2).jpg)
Recommendation
Testing for Pompe disease must be done if any one specialty-specific symptom plus elevated CK/LDH/ALT/AST or a family history of unexplained muscle weakness is present.
*The age of patients with pediatric/juvenile LOPD ranges from 1 to 17 years.
Abbreviations
ALT: Alanine aminotransferase; AST: Aspartate aminotransferase; CK: Creatine kinase; DBS: Dried blood spot testing; KSA: Kingdom of Saudi Arabia; LDH: Lactate dehydrogenase; LGMW: Limb–girdle muscle weakness; LOPD: Late-onset Pompe disease; UAE: United Arab Emirates.
Reference
- Al Shehri A, Al-Asmi A, Al Salti AM, et al. A multidisciplinary perspective addressing the diagnostic challenges of late-onset Pompe disease in the Arabian Peninsula region developed from an Expert Group Meeting. J Neuromuscul Dis. 2022;9(5):661–673.